BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 19788511)

  • 1. Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study.
    Martinez-Saguer I; Rusicke E; Aygören-Pürsün E; von Hentig N; Klingebiel T; Kreuz W
    Transfusion; 2010 Feb; 50(2):354-60. PubMed ID: 19788511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
    Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
    Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema.
    Kreuz W; Rusicke E; Martinez-Saguer I; Aygören-Pürsün E; Heller C; Klingebiel T
    Transfusion; 2012 Jan; 52(1):100-7. PubMed ID: 21756262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.
    Farkas H; Jakab L; Temesszentandrási G; Visy B; Harmat G; Füst G; Széplaki G; Fekete B; Karádi I; Varga L
    J Allergy Clin Immunol; 2007 Oct; 120(4):941-7. PubMed ID: 17761272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanofiltered human C1 inhibitor concentrate (Cinryze®): in hereditary angioedema.
    Lyseng-Williamson KA
    BioDrugs; 2011 Oct; 25(5):317-27. PubMed ID: 21942916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful management with C1-inhibitor concentrate of hereditary angioedema attacks during two successive pregnancies: a case report.
    Hermans C
    Arch Gynecol Obstet; 2007 Sep; 276(3):271-6. PubMed ID: 17653743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
    Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA
    J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prophylaxis of hereditary angioedema with a pasteurized C1 inhibitor concentrate.
    Tallroth GA
    Int Arch Allergy Immunol; 2011; 154(4):356-9. PubMed ID: 20975289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study.
    Bork K; Hardt J; Staubach-Renz P; Witzke G
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):58-64. PubMed ID: 21601496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
    Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary angioedema: long-term treatment with one or more injections of C1 inhibitor concentrate per week.
    Bork K; Hardt J
    Int Arch Allergy Immunol; 2011; 154(1):81-8. PubMed ID: 20664282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks.
    Craig TJ; Rojavin MA; Machnig T; Keinecke HO; Bernstein JA
    Ann Allergy Asthma Immunol; 2013 Sep; 111(3):211-5. PubMed ID: 23987198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target levels of functional C1-inhibitor in hereditary angioedema.
    Hack CE; Relan A; van Amersfoort ES; Cicardi M
    Allergy; 2012 Jan; 67(1):123-30. PubMed ID: 21923668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
    Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
    Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
    Craig TJ; Bewtra AK; Hurewitz D; Levy R; Janss G; Jacobson KW; Packer F; Bernstein JA; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy Asthma Proc; 2012; 33(4):354-61. PubMed ID: 22856636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate.
    Martinez-Saguer I; Rusicke E; Aygören-Pürsün E; Heller C; Klingebiel T; Kreuz W
    Am J Obstet Gynecol; 2010 Aug; 203(2):131.e1-7. PubMed ID: 20471627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks.
    Bernstein JA; Ritchie B; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz DS; Obtulowicz K; Reshef A; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Schindel F; Craig TJ
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):149-54. PubMed ID: 20674826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
    Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
    Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits.
    Bygum A; Andersen KE; Mikkelsen CS
    Eur J Dermatol; 2009; 19(2):147-51. PubMed ID: 19264579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
    Joseph K; Tholanikunnel TE; Kaplan AP
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.